Developer docs
API playgroundTry for free, no card

Search company profiles

CCL Pharmaceuticals

Full company profile

uuid002xgrc

Namestring
CCL Pharmaceuticals
Legal namestring
CCL Holding Pvt. Ltd.
Websiteurl
cclholding.com
Company typeenum
Private
Founded yearint
1965
Descriptiontext

CCL Pharmaceuticals is a Pakistan-headquartered life sciences company operating as a core portfolio company of CCL Holding Pvt. Ltd., a diversified private investment platform. Founded in 1965 and headquartered in Lahore, the company manufactures and distributes prescription and over-the-counter pharmaceuticals spanning cardiometabolic, acute, and specialty care therapeutic areas, alongside consumer health products. Manufacturing is anchored by three facilities — two PIC/S-certified plants in Pakistan and one in Vietnam — supporting exports to 30+ countries across Asia, Africa, the Middle East, Europe, and the Americas. Distribution is conducted through wholesale/retail pharmacy channels and direct supply to hospitals and healthcare institutions.

CCL Holding extends the franchise into adjacent verticals through portfolio companies: Healthwire (an integrated digital health platform offering online consultations, diagnostic lab services, and e-pharmacy delivery in Pakistan); Cozmetica and OneSkin (digital-first e-commerce platforms for curated beauty and science-led skincare serving Pakistani consumers); Mitchell's Fruit Farms (a heritage food company founded in 1933, acquired at 58.78% in October 2025, producing 80+ products across 12 categories); and Biomasdar (Pakistan's first natural ingredients extraction company supplying oleoresins, herbal extracts, essential oils, spray-dried powders, and natural flavors/colors to food, wellness, and pharmaceutical industries globally). The Dilawar Hussain Foundation, the group's philanthropic arm, became a member of the International Diabetes Federation in 2025.

The business model combines one-time-sale revenue from pharmaceutical and consumer health product distribution (manufacturing-led B2B through pharmacy and hospital channels) with transaction-based DTC e-commerce revenue from Cozmetica, OneSkin, and Healthwire's e-pharmacy, and B2B ingredients distribution via Biomasdar. Pricing is not publicly disclosed. Geographic reach is anchored in Pakistan and Vietnam for manufacturing, with international revenue derived from export distribution in 30+ countries (one corporate source citing 40+). The holding company states a long-term, capital-disciplined ownership model across Healthcare & Life Sciences, Food & Beverage, and Beauty & Personal Care, and has positioned itself publicly around sustainability (CERB Sustainability Summit 2025 SDG Leader) and diabetes-focused social impact.

Short descriptiontext

CCL Pharmaceuticals, founded in 1965 and headquartered in Lahore, manufactures cardiometabolic, acute, and specialty care pharmaceuticals plus consumer health products across three facilities (two PIC/S-certified) in Pakistan and Vietnam, distributing to 30+ countries. It operates within CCL Holding's broader healthcare, food, beauty, and digital health portfolio.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersLahore, Pakistan
HQ citystring
Lahore
HQ countrystring
Pakistan
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, cardiometabolic medicines, consumer health products, specialty care pharmaceuticals, PIC/S certified manufacturing
Industry1 code
PRIMARYHLAIACAG
Cardiology & Vascular Specialty Pharmaceuticals
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Medicinal Chemicals & Botanical Products2833
Product category
Pharmaceuticals Manufacturing
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Pharmaceuticals
TypeOne Time License
Description

Manufacture and sale of prescription and OTC pharmaceuticals spanning cardiometabolic, acute, and specialty care therapeutic areas through established pharmaceutical distribution channels.

cclholding.com
2Consumer Health
TypeOne Time License
Description

Sale of consumer health products including over-the-counter medicines and health-related consumer goods.

cclholding.com
3Digital-first beauty and personal care e-commerce
TypeTransaction Fee
Description

Cozmetica and OneSkin operate direct-to-consumer e-commerce platforms in Pakistan offering curated international and local beauty and personal care brands.

cclholding.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

CCL Pharmaceuticals manufactures and sells prescription and over-the-counter pharmaceutical products across cardiometabolic, acute, and specialty care therapeutic areas, with production from two PIC/S-certified plants in Pakistan and a facility in Vietnam. The company also offers consumer health products through its parent platform CCL Holding's portfolio of digital health, beauty and personal care, food and beverage, and natural ingredients businesses.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

CCL Pharmaceuticals is part of CCL Holding's investment portfolio. It is a diversified life sciences company with over six decades of expertise, operating across Pharmaceuticals (cardiometabolic, acute, and specialty care) and Consumer Health divisions, alongside portfolio companies Healthwire (digital health platform), Cozmetica (digital-first beauty platform), OneSkin (skincare brand), Mitchell's Fruit Farms (heritage food company), and Biomasdar (natural ingredients extraction). The company maintains manufacturing facilities in Pakistan and Vietnam.

Product and service7 records
1CCL Pharmaceuticals (Cardiometabolic, Acute, and Specialty Care)
CategoryPharmaceuticals
Description

Manufacture and distribution of prescription and over-the-counter pharmaceutical products spanning cardiometabolic, acute, and specialty care therapeutic areas for healthcare providers, hospitals, and pharmacies.

2CCL Pharmaceuticals Consumer Health
CategoryConsumer Health
Description

Science-backed consumer health products offered alongside the pharmaceutical portfolio, delivered through retail and digital channels.

3Healthwire
CategoryDigital Health
Description

Integrated digital health platform offering online doctor consultations, diagnostic lab services, and e-pharmacy with medicine delivery for consumers in Pakistan.

4Cozmetica
CategoryBeauty and Personal Care E-commerce
Description

Digital-first beauty and personal care e-commerce platform serving Pakistani consumers with a curated mix of international and local brands.

5OneSkin
CategorySkincare Brand
Description

Digital-first skincare brand offering clean, science-led formulations tailored for modern skin needs in Pakistan.

6Mitchell's Fruit Farms
CategoryFood and Beverage
Description

Heritage food company producing over 80 products across 12 categories including beverages, jams and spreads, confectionery, and processed foods, distributed through retail channels in Pakistan.

7Biomasdar
CategoryNatural Ingredients Extraction
Description

Pakistan's first natural ingredients extraction company delivering clean-label, plant-based solutions for food, wellness, and pharmaceutical industries, with capabilities spanning oleoresins, herbal extracts, essential oils, spray-dried powders, and natural flavors and colors.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-16
Description

CCL Holding acquired 13,447,058 ordinary shares, representing 58.78% of the total issued ordinary share capital of Mitchell's Fruit Farms Ltd. on October 16, 2025. Mitchell's is a heritage food company founded in 1933, producing over 80 products across 12 categories including beverages, jams, confectionery, and processed foods. The acquisition expands CCL Holding's Food & Beverage portfolio.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Dilawar Hussain Foundation (DHF), the philanthropic arm of CCL Holding, became an official member of the International Diabetes Federation in 2025. IDF is a global umbrella organisation with over 250 national diabetes associations in 160+ countries. The membership supports DHF's diabetes care, prevention, and awareness programs in Pakistan and aligns with global standards.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-01-01
Description

CCL Pharmaceuticals participated as an SDG Leader at the CERB Sustainability Summit 2025. CERB is an initiative of the Pakistan Business Council that brings together business leaders to accelerate responsible business conduct, promoting climate action, environmental stewardship, and UN Sustainable Development Goals.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Highnoon Laboratories is a publicly listed Pakistani pharma company manufacturing branded generics and consumer health products for domestic and export markets — comparable to CCL's manufacturing scale, therapeutic breadth, and export-driven business model.

2Abbott Laboratories
TypeBroad incumbent
Description

Abbott is a diversified global healthcare major with established branded generics and consumer health presence in emerging Asia — overlapping with CCL's prescription and consumer health portfolios as a multinational incumbent.

TypeDirect peer
Description

Sami Pharmaceuticals is a Pakistani specialty pharma manufacturer serving domestic and export markets with branded prescription products — comparable to CCL in product positioning and Pakistan-domestic manufacturing footprint.

TypeBroad incumbent
Description

Sanofi is a global pharmaceutical major with a strong cardiometabolic and specialty-care franchise serving emerging markets — broader but directly competitive with CCL in the cardiometabolic space where Sanofi fields branded originator products.

TypeDirect peer
Description

PharmEvo is a leading Pakistani pharmaceutical company focused on cardiometabolic, neurology, and critical-care therapeutics with international presence — directly comparable to CCL's specialty therapeutic concentration and emerging-market export footprint.

TypeDirect peer
Description

Hilton Pharma is a top-tier Pakistani pharmaceutical manufacturer with branded generics across therapeutic areas including cardiology, served through a national sales force — directly comparable to CCL in product breadth, therapeutic focus, and domestic Pakistani market presence.

TypeBroad incumbent
Description

Bayer is a global pharmaceutical incumbent with a deep cardiology and women's health specialty franchise serving emerging markets — competes with CCL's cardiometabolic focus from a multinational origin-brand position.

TypeDirect peer
Description

Getz Pharma is one of Pakistan's largest privately held pharmaceutical manufacturers with a multi-therapeutic portfolio spanning cardio, diabetes, CNS, and consumer health, exporting to multiple emerging markets — highly comparable to CCL in scale, geography, regulatory positioning, and cardiometabolic emphasis.

TypeDirect peer
Description

AGP Limited is one of Pakistan's largest pharmaceutical manufacturers with a diversified branded-generics portfolio and significant export operations — comparable to CCL in scale, business model, and therapeutic coverage.

TypeBroad incumbent
Description

GSK Pakistan is the local subsidiary of a global pharmaceutical incumbent with deep therapy-area breadth and prescriber relationships across Pakistan — overlapping with CCL on therapeutic categories but competing as a multinational with global R&D backing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CCL Pharmaceuticals

Pharmaceuticals Manufacturingcclholding.com

CCL Pharmaceuticals, founded in 1965 and headquartered in Lahore, manufactures cardiometabolic, acute, and specialty care pharmaceuticals plus consumer health products across three facilities (two PIC/S-certified) in Pakistan and Vietnam, distributing to 30+ countries. It operates within CCL Holding's broader healthcare, food, beauty, and digital health portfolio.

What CCL Pharmaceuticals does

CCL Pharmaceuticals is a Pakistan-headquartered life sciences company operating as a core portfolio company of CCL Holding Pvt. Ltd., a diversified private investment platform. Founded in 1965 and headquartered in Lahore, the company manufactures and distributes prescription and over-the-counter pharmaceuticals spanning cardiometabolic, acute, and specialty care therapeutic areas, alongside consumer health products. Manufacturing is anchored by three facilities — two PIC/S-certified plants in Pakistan and one in Vietnam — supporting exports to 30+ countries across Asia, Africa, the Middle East, Europe, and the Americas. Distribution is conducted through wholesale/retail pharmacy channels and direct supply to hospitals and healthcare institutions.

CCL Holding extends the franchise into adjacent verticals through portfolio companies: Healthwire (an integrated digital health platform offering online consultations, diagnostic lab services, and e-pharmacy delivery in Pakistan); Cozmetica and OneSkin (digital-first e-commerce platforms for curated beauty and science-led skincare serving Pakistani consumers); Mitchell's Fruit Farms (a heritage food company founded in 1933, acquired at 58.78% in October 2025, producing 80+ products across 12 categories); and Biomasdar (Pakistan's first natural ingredients extraction company supplying oleoresins, herbal extracts, essential oils, spray-dried powders, and natural flavors/colors to food, wellness, and pharmaceutical industries globally). The Dilawar Hussain Foundation, the group's philanthropic arm, became a member of the International Diabetes Federation in 2025.

The business model combines one-time-sale revenue from pharmaceutical and consumer health product distribution (manufacturing-led B2B through pharmacy and hospital channels) with transaction-based DTC e-commerce revenue from Cozmetica, OneSkin, and Healthwire's e-pharmacy, and B2B ingredients distribution via Biomasdar. Pricing is not publicly disclosed. Geographic reach is anchored in Pakistan and Vietnam for manufacturing, with international revenue derived from export distribution in 30+ countries (one corporate source citing 40+). The holding company states a long-term, capital-disciplined ownership model across Healthcare & Life Sciences, Food & Beverage, and Beauty & Personal Care, and has positioned itself publicly around sustainability (CERB Sustainability Summit 2025 SDG Leader) and diabetes-focused social impact.

CCL Pharmaceuticals firmographics

Firmographics
Name
CCL Pharmaceuticals
Legal name
CCL Holding Pvt. Ltd.
Website
https://cclholding.com
Company type
Private
Founded year
1965
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
CCL Pharmaceuticals, founded in 1965 and headquartered in Lahore, manufactures cardiometabolic, acute, and specialty care pharmaceuticals plus consumer health products across three facilities (two PIC/S-certified) in Pakistan and Vietnam, distributing to 30+ countries. It operates within CCL Holding's broader healthcare, food, beauty, and digital health portfolio.
Ownership category
akta.pro rank

CCL Pharmaceuticals industry classification

Industry
Product category
Pharmaceuticals Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAIACAG
Cardiology & Vascular Specialty Pharmaceuticals

Keywords

  • Pharmaceutical manufacturing
  • Cardiometabolic medicines
  • Consumer health products
  • Specialty care pharmaceuticals
  • PIC/S certified manufacturing

Where CCL Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Lahore
HQ country
Pakistan
HQ region
Asia

Offices2 records

Markets served

CCL Pharmaceuticals business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceuticals: Manufacture and sale of prescription and OTC pharmaceuticals spanning cardiometabolic, acute, and specialty care therapeutic areas through established pharmaceutical distribution channels.
  2. Consumer Health: Sale of consumer health products including over-the-counter medicines and health-related consumer goods.
  3. Digital-first beauty and personal care e-commerce: Cozmetica and OneSkin operate direct-to-consumer e-commerce platforms in Pakistan offering curated international and local beauty and personal care brands.

Go-to-market motion2 records

Distribution channels7 records

Marketing channels3 records

CCL Pharmaceuticals product offering

Product offering

Core offering

CCL Pharmaceuticals manufactures and sells prescription and over-the-counter pharmaceutical products across cardiometabolic, acute, and specialty care therapeutic areas, with production from two PIC/S-certified plants in Pakistan and a facility in Vietnam. The company also offers consumer health products through its parent platform CCL Holding's portfolio of digital health, beauty and personal care, food and beverage, and natural ingredients businesses.

Product overview

CCL Pharmaceuticals is part of CCL Holding's investment portfolio. It is a diversified life sciences company with over six decades of expertise, operating across Pharmaceuticals (cardiometabolic, acute, and specialty care) and Consumer Health divisions, alongside portfolio companies Healthwire (digital health platform), Cozmetica (digital-first beauty platform), OneSkin (skincare brand), Mitchell's Fruit Farms (heritage food company), and Biomasdar (natural ingredients extraction). The company maintains manufacturing facilities in Pakistan and Vietnam.

Differentiator

Problem solved

Functional benefit

Products and services

  • CCL Pharmaceuticals (Cardiometabolic, Acute, and Specialty Care) Manufacture and distribution of prescription and over-the-counter pharmaceutical products spanning cardiometabolic, acute, and specialty care therapeutic areas for healthcare providers, hospitals, and pharmacies.
  • CCL Pharmaceuticals Consumer Health Science-backed consumer health products offered alongside the pharmaceutical portfolio, delivered through retail and digital channels.
  • Healthwire Integrated digital health platform offering online doctor consultations, diagnostic lab services, and e-pharmacy with medicine delivery for consumers in Pakistan.
  • Cozmetica Digital-first beauty and personal care e-commerce platform serving Pakistani consumers with a curated mix of international and local brands.
  • OneSkin Digital-first skincare brand offering clean, science-led formulations tailored for modern skin needs in Pakistan.
  • Mitchell's Fruit Farms Heritage food company producing over 80 products across 12 categories including beverages, jams and spreads, confectionery, and processed foods, distributed through retail channels in Pakistan.
  • Biomasdar Pakistan's first natural ingredients extraction company delivering clean-label, plant-based solutions for food, wellness, and pharmaceutical industries, with capabilities spanning oleoresins, herbal extracts, essential oils, spray-dried powders, and natural flavors and colors.

Companies that use CCL Pharmaceuticals

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles3 records

CCL Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

CCL Pharmaceuticals partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Mitchell's Fruit Farms Ltd.coreStrategic or Co-development Partner · 16 October 2025CCL Holding acquired 13,447,058 ordinary shares, representing 58.78% of the total issued ordinary share capital of Mitchell's Fruit Farms Ltd. on October 16, 2025. Mitchell's is a heritage food company founded in 1933, producing over 80 products across 12 categories including beverages, jams, confectionery, and processed foods. The acquisition expands CCL Holding's Food & Beverage portfolio.
  • International Diabetes Federation (IDF)coreStrategic or Co-development Partner · 1 January 2025Dilawar Hussain Foundation (DHF), the philanthropic arm of CCL Holding, became an official member of the International Diabetes Federation in 2025. IDF is a global umbrella organisation with over 250 national diabetes associations in 160+ countries. The membership supports DHF's diabetes care, prevention, and awareness programs in Pakistan and aligns with global standards.
  • Centre of Excellence in Responsible Business (CERB) / Pakistan Business CouncilminorGTM or Marketing Partner · 1 January 2025CCL Pharmaceuticals participated as an SDG Leader at the CERB Sustainability Summit 2025. CERB is an initiative of the Pakistan Business Council that brings together business leaders to accelerate responsible business conduct, promoting climate action, environmental stewardship, and UN Sustainable Development Goals.

Scale indicators7 records

Recent moves5 records

Expansion highlights6 records

CCL Pharmaceuticals competitors and assessment

Company assessment

Direct peers

  • Highnoon Laboratories: Highnoon Laboratories is a publicly listed Pakistani pharma company manufacturing branded generics and consumer health products for domestic and export markets — comparable to CCL's manufacturing scale, therapeutic breadth, and export-driven business model.
  • Sami Pharmaceuticals: Sami Pharmaceuticals is a Pakistani specialty pharma manufacturer serving domestic and export markets with branded prescription products — comparable to CCL in product positioning and Pakistan-domestic manufacturing footprint.
  • PharmEvo: PharmEvo is a leading Pakistani pharmaceutical company focused on cardiometabolic, neurology, and critical-care therapeutics with international presence — directly comparable to CCL's specialty therapeutic concentration and emerging-market export footprint.
  • Hilton Pharma: Hilton Pharma is a top-tier Pakistani pharmaceutical manufacturer with branded generics across therapeutic areas including cardiology, served through a national sales force — directly comparable to CCL in product breadth, therapeutic focus, and domestic Pakistani market presence.
  • Getz Pharma: Getz Pharma is one of Pakistan's largest privately held pharmaceutical manufacturers with a multi-therapeutic portfolio spanning cardio, diabetes, CNS, and consumer health, exporting to multiple emerging markets — highly comparable to CCL in scale, geography, regulatory positioning, and cardiometabolic emphasis.
  • AGP Limited: AGP Limited is one of Pakistan's largest pharmaceutical manufacturers with a diversified branded-generics portfolio and significant export operations — comparable to CCL in scale, business model, and therapeutic coverage.

Broad incumbents

  • Abbott Laboratories: Abbott is a diversified global healthcare major with established branded generics and consumer health presence in emerging Asia — overlapping with CCL's prescription and consumer health portfolios as a multinational incumbent.
  • Sanofi: Sanofi is a global pharmaceutical major with a strong cardiometabolic and specialty-care franchise serving emerging markets — broader but directly competitive with CCL in the cardiometabolic space where Sanofi fields branded originator products.
  • Bayer Pharmaceuticals: Bayer is a global pharmaceutical incumbent with a deep cardiology and women's health specialty franchise serving emerging markets — competes with CCL's cardiometabolic focus from a multinational origin-brand position.
  • GSK Pakistan: GSK Pakistan is the local subsidiary of a global pharmaceutical incumbent with deep therapy-area breadth and prescriber relationships across Pakistan — overlapping with CCL on therapeutic categories but competing as a multinational with global R&D backing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

CCL Pharmaceuticals social profiles

Digital presence

CCL Pharmaceuticals compliance and trust

Trust signal

Compliance1 record

CCL Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CCL Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles1 record

CCL Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CCL Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CCL Pharmaceuticals

What does CCL Pharmaceuticals do?

CCL Pharmaceuticals manufactures and sells prescription and over-the-counter pharmaceutical products across cardiometabolic, acute, and specialty care therapeutic areas, with production from two PIC/S-certified plants in Pakistan and a facility in Vietnam. The company also offers consumer health products through its parent platform CCL Holding's portfolio of digital health, beauty and personal care, food and beverage, and natural ingredients businesses.

Is CCL Pharmaceuticals a public or private company?

CCL Pharmaceuticals is a private company. It is classified as corporate owned and is currently operating.

When was CCL Pharmaceuticals founded?

CCL Pharmaceuticals was founded in 1965. It employs 1,001 to 5,000 people.

Where is CCL Pharmaceuticals based?

CCL Pharmaceuticals is headquartered in Lahore, Pakistan, in the Asia region.

How does CCL Pharmaceuticals make money?

Three revenue lines are on record. Pharmaceuticals are the primary driver. The others are consumer Health and digital-first beauty and personal care e-commerce.

Who are CCL Pharmaceuticals's main competitors?

Direct peers on record are Highnoon Laboratories, Sami Pharmaceuticals, PharmEvo, Hilton Pharma, Getz Pharma and AGP Limited. Broad incumbents are Abbott Laboratories, Sanofi, Bayer Pharmaceuticals and GSK Pakistan.

Does CCL Pharmaceuticals have an API?

No public API is recorded for CCL Pharmaceuticals.

What industry is CCL Pharmaceuticals in?

CCL Pharmaceuticals's product category is Pharmaceuticals Manufacturing. Its primary akta.pro industry code is HLAIACAG, Cardiology & Vascular Specialty Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales